| Literature DB >> 33972511 |
Saad Khan1,2, Helen Luck2, Shawn Winer3,4, Daniel A Winer5,6,7,8,9.
Abstract
The intestinal immune system is an important modulator of glucose homeostasis and obesity-associated insulin resistance. Dietary factors, the intestinal microbiota and their metabolites shape intestinal immunity during obesity. The intestinal immune system in turn affects processes such as intestinal permeability, immune cell trafficking, and intestinal hormone availability, impacting systemic insulin resistance. Understanding these pathways might identify mechanisms underlying treatments for insulin resistance, such as metformin and bariatric surgery, or aid in developing new therapies and vaccination approaches. Here, we highlight evolving concepts centered on intestinal immunity, diet, and the microbiota to provide a working model of obesity-related metabolic disease.Entities:
Year: 2021 PMID: 33972511 DOI: 10.1038/s41467-021-22727-7
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919